House report questions FDA’s approval of Alzheimer’s drug ...Middle East

A joint investigation released Thursday by House Democrats identified unusual collaboration between Food and Drug Administration officials and Alzheimer’s drugmaker Biogen, highlighting potential problems in the agency’s approval of the controversial drug Aduhelm. The House Energy and Commerce and Oversight and Reform committees concluded their findings “raise serious concerns” about the drug’s approval process. “The number […] The post House report questions FDA’s approval of Alzheimer’s drug appeared first on Roll Call.

Read More Details
Finally We wish PressBee provided you with enough information of ( House report questions FDA’s approval of Alzheimer’s drug )

Also on site :

• 105 'Magical' Baby Names for Your Little Spell Caster
• ‘Honey Don’t!’ Review: Margaret Qualley, Aubrey Plaza and Chris Evans Get Stranded in Ethan Coen’s Wayward Whodunit
• Naukri exposed recruiter email addresses, researcher says